Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
What explains functioning from the perspective of people with multiple sclerosis?
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Effects of yoga interventions on fatigue: a meta-analysis.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
LSN MS guidelines for the management of multiple sclerosis.
New hope for multiple sclerosis patients.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
Suicidal Behavior and Neurological Illnesses.
Primary varicella zoster infection associated with fingolimod treatment.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Cell fusion in the brain: two cells forward, one cell back.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Experimental Autoimmune Encephalomyelitis in Mice.
Experience with Fingolimod in Clinical Practice.
Atorvastatin: Multiple Sclerosis.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
7 Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »